Meredith Spadaccia
Icahn School of Medicine at Mount Sinai(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Immune Response and Inflammation, RNA Interference and Gene Delivery, HIV Research and Treatment, T-cell and B-cell Immunology
Most-Cited Works
- → Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma(2015)91 cited
- → Plasma Factors During Chronic HIV-1 Infection Impair IL-12 Secretion by Myeloid Dendritic Cells via a Virus-Independent Pathway(2012)34 cited
- → Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy(2013)20 cited
- → Attenuated Listeria monocytogenes Vectors Overcome Suppressive Plasma Factors During HIV Infection to Stimulate Myeloid Dendritic Cells to Promote Adaptive Immunity and Reactivation of Latent Virus(2014)10 cited
- → Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid–poly-l-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy(2014)10 cited
- → Phase I/II study of the TLR3 agonist poly-ICLC as an adjuvant for NY-ESO-1 protein vaccination with or without Montanide ISA-51 vg in patients with melanoma.(2014)3 cited
- → P3‐415: TESTING OF INNATE IMMUNITY STIMULATION VIA TLR9 ON CEREBRAL AMYLOID ANGIOPATHY USING NON‐HUMAN PRIMATES(2014)1 cited
- → Poly-ICLC as an adjuvant for NY-ESO-1 protein vaccination with or without Montanide ISA-51 VG in patients with melanoma.(2015)